XML 86 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Beginning balance (shares) at Dec. 31, 2016   19,937,095      
Beginning balance at Dec. 31, 2016 $ 48,309 $ 20 $ 428,507 $ 9,533 $ (389,751)
Increase (Decrease) in Stockholders' Equity          
Net loss (70,430)       (70,430)
Issuance of common stock and warrants, net of issuance costs (shares)   7,941,688      
Issuance of common stock and warrants, net of issuance costs 153,530 $ 8 153,522    
Share-based compensation expense 6,786   6,786    
Issuance of common stock from ESPP (shares)   59,976      
Issuance of common stock from ESPP 144   144    
Exercise of options for cash (shares)   45,573      
Exercise of options for cash $ 399   399    
Exercise of warrants for cash (shares) 585,729 585,729      
Exercise of warrants for cash $ 4,604 $ 1 4,603    
Net exercise of warrants (shares) 638,554 52,825      
Unrealized gain (loss) on investments $ (54)     (54)  
Ending balance (shares) at Dec. 31, 2017   28,622,886      
Ending balance at Dec. 31, 2017 143,288 $ 29 594,407 9,479 (460,627)
Increase (Decrease) in Stockholders' Equity          
Net loss (98,418)       (98,418)
Issuance of common stock and warrants, net of issuance costs (shares)   3,162,500      
Issuance of common stock and warrants, net of issuance costs 130,663 $ 3 130,660    
Share-based compensation expense 15,854   15,854    
Issuance of common stock from ESPP (shares)   21,536      
Issuance of common stock from ESPP 442   442    
Exercise of options for cash (shares)   731,935      
Exercise of options for cash 9,747 $ 1 9,746    
Unrealized gain (loss) on investments $ 0        
Ending balance (shares) at Dec. 31, 2018 32,538,857 32,538,857      
Ending balance at Dec. 31, 2018 $ 201,576 $ 33 751,109 9,479 (559,045)
Increase (Decrease) in Stockholders' Equity          
Net loss (213,256)       (213,256)
Issuance of common stock and warrants, net of issuance costs (shares)   4,269,838      
Issuance of common stock and warrants, net of issuance costs 327,830 $ 4 327,826    
Share-based compensation expense 55,537   55,537    
Issuance of common stock from ESPP (shares)   14,488      
Issuance of common stock from ESPP $ 675   675    
Exercise of options for cash (shares) 569,146 569,146      
Exercise of options for cash $ 8,473 $ 1 8,472    
Adjustments to Additional Paid-in-Capital, Disgorgement of Stockholders' Short-Swing Profits $ 1,050   1,050    
Net exercise of warrants (shares) 2,125,000 2,125,000      
Net exercise of warrants   $ 2 (2)    
Unrealized gain (loss) on investments $ 410     410  
Ending balance (shares) at Dec. 31, 2019 39,517,329 39,517,329      
Ending balance at Dec. 31, 2019 $ 382,295 $ 40 $ 1,144,667 $ 9,889 $ (772,301)